X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (531) 531
Publication (20) 20
Book Review (19) 19
Book / eBook (18) 18
Book Chapter (6) 6
Conference Proceeding (1) 1
Dissertation (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (192) 192
index medicus (180) 180
psychiatry (155) 155
female (153) 153
male (150) 150
schizophrenia (114) 114
adult (112) 112
middle aged (83) 83
psychiatric/mental health (62) 62
adolescent (60) 60
bipolar disorder (52) 52
spain (48) 48
prevalence (47) 47
depression (45) 45
neurosciences (41) 41
cross-sectional studies (40) 40
young adult (38) 38
analysis (36) 36
clinical neurology (36) 36
internal medicine (35) 35
adolescents (29) 29
risk factors (29) 29
treatment outcome (29) 29
surveys and questionnaires (28) 28
risk (27) 27
comorbidity (26) 26
mental health (26) 26
pharmacology & pharmacy (26) 26
psychiatric status rating scales (26) 26
substance abuse (26) 26
teenagers (26) 26
antipsychotic agents - therapeutic use (25) 25
schizophrenic psychology (25) 25
aged (24) 24
esquizofrenia (24) 24
reliability (23) 23
suicide (23) 23
antipsychotics (22) 22
prospective studies (22) 22
follow-up studies (21) 21
psychometric properties (21) 21
psychopathology (21) 21
schizophrenia - drug therapy (21) 21
disorders (20) 20
mental disorders (20) 20
psychosis (20) 20
validity (20) 20
care and treatment (19) 19
cognition (19) 19
europe (19) 19
metaanalysis (19) 19
metabolic syndrome (19) 19
negative symptoms (19) 19
symptoms (19) 19
consensus (18) 18
epidemiology (18) 18
quality of life (18) 18
youth (18) 18
antipsychotic agents - adverse effects (17) 17
anxiety (17) 17
medical research (17) 17
psychometrics (17) 17
schizophrenia - diagnosis (17) 17
suicidal ideation (17) 17
mortality (16) 16
rating-scale (16) 16
research (16) 16
physical health (15) 15
prevention (15) 15
reproducibility of results (15) 15
seyle (15) 15
studies (15) 15
suicides & suicide attempts (15) 15
validation (15) 15
association (14) 14
psychology, clinical (14) 14
spain - epidemiology (14) 14
animals (13) 13
case-control studies (13) 13
diagnosis (13) 13
double-blind (13) 13
medicine (13) 13
medicine, experimental (13) 13
mental depression (13) 13
psychology (13) 13
randomized controlled-trial (13) 13
sex factors (13) 13
adolescence (12) 12
antipsychotic drugs (12) 12
behavior (12) 12
follow-up (12) 12
genetic aspects (12) 12
genetic association (12) 12
severity of illness index (12) 12
trastorno bipolar (12) 12
trial (12) 12
bipolar disorder - psychology (11) 11
clinical trials (11) 11
cognitive impairment (11) 11
cysticercosis (11) 11
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2015, Volume 385, Issue 9977, pp. 1536 - 1544
Journal Article
Psychological Medicine, ISSN 0033-2917, 06/2019, Volume 49, Issue 8, pp. 1378 - 1391
Journal Article
Psychological Medicine, ISSN 0033-2917, 10/2018, Volume 48, Issue 13, pp. 2247 - 2256
Background. Cognitive deficits are a core feature of early stages in schizophrenia. However, the extent to which antipsychotic (AP) have a deleterious effect... 
antipsychotics | Anticholinergic | first episode psychosis | cognition | premorbid intellectual quotient | 1ST EPISODE | PSYCHIATRY | CONSENSUS | CHRONIC-SCHIZOPHRENIA | OPEN-LABEL | RISPERIDONE | PSYCHOLOGY, CLINICAL | PSYCHOLOGY | SYNDROME SCALE PANSS | NAIVE PATIENTS | NEUROPSYCHOLOGICAL PERFORMANCE | DOUBLE-BLIND | OLANZAPINE | Cross-Sectional Studies | Psychotic Disorders - complications | Antipsychotic Agents - adverse effects | Humans | Male | Antipsychotic Agents - pharmacokinetics | Cognitive Dysfunction - etiology | Cognitive Dysfunction - physiopathology | Cholinergic Antagonists - pharmacology | Cholinergic Antagonists - administration & dosage | Antipsychotic Agents - administration & dosage | Young Adult | Psychotic Disorders - physiopathology | Intelligence - physiology | Adult | Female | Psychotic Disorders - drug therapy | Antipsychotic Agents - pharmacology | Cognitive Dysfunction - chemically induced | Cholinergic Antagonists - adverse effects | Neuroleptics | Intelligence | Mental disorders | Memory | Cognitive ability | Science | Schizophrenia | Cognitive deficits | Chlorpromazine | Psychosis | Psychotropic drugs | Intelligence tests | Cognitive performance | Psychoses | Remission | First time | Drug dosages | Research centers | Dopamine receptors | Cognitive impairment | Medical research | Dopamine | Research funding | Advisors | Patients | Studies | Verbal memory | Cognition & reasoning | Hallucinations | Information processing | Acetylcholine receptors | Premorbid | Index Medicus
Journal Article
by Jongsma, Hannah E and Gayer-Anderson, Charlotte and Lasalvia, Antonio and Quattrone, Diego and Mulè, Alice and Szöke, Andrei and Selten, Jean-Paul and Turner, Caitlin and Arango, Celso and Tarricone, Ilaria and Berardi, Domenico and Tortelli, Andrea and Llorca, Pierre-Michel and De Haan, Lieuwe and Bobes, Julio and Bernardo, Miguel and Sanjuán, Julio and Santos, José Luis and Arrojo, Manuel and Del-Ben, Cristina Marta and Menezes, Paulo Rossi and Murray, Robin M and Rutten, Bart P and Jones, Peter B and Van Os, Jim and Morgan, Craig and Kirkbride, James B and Reininghaus, Ulrich and Di Forti, Marta and Hubbard, Kathryn and Beards, Stephanie and Stilo, Simona A and Tripoli, Giada and Parellada, Mara and Cuadrado, Pedro and Solano, José Juan Rodríguez and Carracedo, Angel and Bernardo, Enrique García and Roldán, Laura and López, Gonzalo and Cabrera, Bibiana and Lorente-Rovira, Esther and Garcia-Portilla, Paz and Costas, Javier and Jiménez-López, Estela and Matteis, Mario and Rapado, Marta and González, Emiliano and Martínez, Covadonga and Sánchez, Emilio and Olmeda, Ma Soledad and Franke, Nathalie and Velthorst, Eva and Termorshuizen, Fabian and Van Dam, Daniella and Van Der Ven, Elsje and Messchaart, Elles and Leboyer, Marion and Schürhoff, Franck and Jamain, Stéphane and Frijda, Flora and Baudin, Grégoire and Ferchiou, Aziz and Pignon, Baptiste and Richard, Jean-Romain and Charpeaud, Thomas and Tronche, Anne-Marie and La Barbera, Daniele and La Cascia, Caterina and Marrazzo, Giovanna and Sideli, Lucia and Sartorio, Crocettarachele and Ferraro, Laura and Seminerio, Fabio and Loureiro, Camila Marcelino and Shuhama, Rosana and Ruggeri, Mirella and Tosato, Sarah and Bonetto, Chiara and Cristofalo, Doriana and European Network Natl and European Network of National Schizophrenia Networks Studying Gene-Environment Interactions Work Package 2 (EU-GEI WP2) Group and for the European Network of National Schizophrenia Networks Studying Gene-Environment Interactions Work Package 2 (EU-GEI WP2) Group
JAMA Psychiatry, ISSN 2168-622X, 01/2018, Volume 75, Issue 1, pp. 36 - 46
IMPORTANCE Psychotic disorders contribute significantly to the global disease burden, yet the latest international incidence study of psychotic disorders was... 
RATES | METAANALYSIS | DEPRIVATION | PSYCHIATRY | NOTTINGHAM | SCHIZOPHRENIA | SYMPTOMS | OUTCOMES | 1ST-EPISODE PSYCHOSIS | URBANICITY | AGE | Index Medicus | Abridged Index Medicus | Life Sciences | Neuroscience | Neurons and Cognition | Psychology and behavior | Neurobiology | Cognitive Sciences | Cognitive science | Online First | Original Investigation | Research
Journal Article